BioSpace News Archive

Ophthalmology Surgical Devices Market Size to Surpass USD 14 BN by 2030

According to Report, the ophthalmic surgical devices market size is expected to surpass around USD 14 billion by 2030 and is poised to grow at a noteworthy CAGR of 6% during the forecast period 2021 to 2030.

April 26, 2022
·
5 min read
Veterinary Medicine Market Size to Surpass US$ 55.8 BN by 2030

The global veterinary medicine market size is expected to surpass around US$ 55.8 billion by 2030 from valued at US$ 30.2 billion in 2020 with CAGR of 8.4% from 2021 to 2030.

April 26, 2022
·
5 min read
The Versi™PD Cycler System conceived and developed by Debiotech and licensed to Fresenius Medical Care receives FDA clearance

Debiotech, a leading Swiss innovation company in the field of medical devices, announced today that the Versi™PD Cycler System, developed in close collaboration with its licensee Fresenius Medical Care, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

April 26, 2022
·
3 min read
Pharm Country

Royal Biologics Announces U.S. Commercial Launch of Advanced-Cell™, an Advanced Bone Grafting and Fusion Convenience Kit

Royal Biologics (Hackensack, NJ), a company specializing in Advanced Cellular & Autologous Technologies for Enhanced Healing, today announced the U.S. commercial launch of Advanced - Cell™, an advanced fusion bone grafting system for use in orthopedics.

April 26, 2022
·
3 min read
Business

Medicure To Report Financial Results For Year Ended December 31, 2021 On April 28th At 7:30 AM CST

Medicure Inc., a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, announces Medicure’s 2021 Year End Results Conference Call.

April 26, 2022
·
5 min read
Drug Development

VITRAC Therapeutics Initiates a Phase 1/2 Clinical Trial with the Aurora Kinase A inhibitor VIC-1911 in GVHD Prophylaxis

VITRAC Therapeutics, LLC (VITRAC) initiated a Phase 1/2 clinical trial of VIC-1911 in combination with sirolimus and post-transplant cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis in myeloablative allogeneic stem cell transplantation.

April 26, 2022
·
3 min read
Biotech Beach

AtaCor Medical to Present Preliminary Results from First-in-Human Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Study

AtaCor Medical, Inc. (“AtaCor”) announced today that it will present initial findings from its first-in-human extravascular implantable cardioverter defibrillator (EV-ICD) study during the upcoming Stanford Biodesign New Arrhythmia Technologies Retreat.

April 26, 2022
·
3 min read
Pulmonary Drug Delivery Systems Market Size to Worth USD 92.4 BN by 2030

The global pulmonary drug delivery systems market was estimated at USD 51.87 billion in 2021, and it is expected to be worth around USD 92.4 billion by 2030 with a CAGR of 6.6% in next 10 years.

April 26, 2022
·
5 min read
In-Vitro Fertilization Market Size to Surpass USD 33 BN by 2030

The global in-vitro fertilization market is expected to grow at 8.6% from 2021 to 2030 and it is projected to surpass around USD 33 Billion by 2030.

April 26, 2022
·
5 min read
Topical Drug Delivery Market Size to Worth US$ 161.59 BN by 2029

According to Report, the global topical drug delivery market size is projected to be worth around US$ 161.59 billion by 2029 and growing at a CAGR of 6.7% from 2022 to 2030.

April 26, 2022
·
5 min read